Skip to main content
. 2015 Oct 19;6(36):38487–38503. doi: 10.18632/oncotarget.5750

Figure 5. Adoptive transfer of immune cells from infected and uninfected BALB/c into NP8 mice.

Figure 5

A. Scheme depicting the time point of splenocyte transfer from five individually infected BALB/c mice into the corresponding number of transgenic mice and harvest of their mammary glands; the calculated relative amounts of T-Ag positive cells are shown as percentage in brackets. B. NP8 mice received either the spleen cells of BALB/c mice infected with the VV recombinants containing the NP of LCMV (VV-YN4, c) [2–4%] or the T-Ag of SV40 (VV-941T, d) [~100%]; mammary glands of NP8 mice, which received spleen cells from LCMV-infected BALB/c mice (LCMV, a) [2–6%] or none (Co, b) [100%] served as positive and negative controls.